Vis enkel innførsel

dc.contributor.authorAndreasen, Jane
dc.contributor.authorNørgaard, Birgitte
dc.contributor.authorDraborg, Eva
dc.contributor.authorJuhl, Carsten Bogh
dc.contributor.authorYost, Jennifer
dc.contributor.authorBrunnhuber, Klara
dc.contributor.authorRobinson, Karen A.
dc.contributor.authorLund, Hans Aage
dc.date.accessioned2023-03-17T13:18:26Z
dc.date.available2023-03-17T13:18:26Z
dc.date.created2022-11-29T13:27:21Z
dc.date.issued2022
dc.identifier.citationPLOS ONE. 2022, 17 (10), .en_US
dc.identifier.issn1932-6203
dc.identifier.urihttps://hdl.handle.net/11250/3059039
dc.description.abstractBackground Redundancy is an unethical, unscientific, and costly challenge in clinical health research. There is a high risk of redundancy when existing evidence is not used to justify the research question when a new study is initiated. Therefore, the aim of this study was to synthesize meta-research studies evaluating if and how authors of clinical health research studies use systematic reviews when initiating a new study. Methods Seven electronic bibliographic databases were searched (final search June 2021). Meta-research studies assessing the use of systematic reviews when justifying new clinical health studies were included. Screening and data extraction were performed by two reviewers independently. The primary outcome was defined as the percentage of original studies within the included meta-research studies using systematic reviews of previous studies to justify a new study. Results were synthesized narratively and quantitatively using a random-effects meta-analysis. The protocol has been registered in Open Science Framework (https://osf.io/nw7ch/). Results Twenty-one meta-research studies were included, representing 3,621 original studies or protocols. Nineteen of the 21 studies were included in the meta-analysis. The included studies represented different disciplines and exhibited wide variability both in how the use of previous systematic reviews was assessed, and in how this was reported. The use of systematic reviews to justify new studies varied from 16% to 87%. The mean percentage of original studies using systematic reviews to justify their study was 42% (95% CI: 36% to 48%). Conclusion Justification of new studies in clinical health research using systematic reviews is highly variable, and fewer than half of new clinical studies in health science were justified using a systematic review. Research redundancy is a challenge for clinical health researchers, as well as for funders, ethics committees, and journals.en_US
dc.language.isoengen_US
dc.publisherPublic Library of Scienceen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleJustification of research using systematic reviews continues to be inconsistent in clinical health science—A systematic review and meta-analysis of meta-research studiesen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.rights.holder© 2022 Andreasen et al.en_US
dc.source.pagenumber17en_US
dc.source.volume17en_US
dc.source.journalPLOS ONEen_US
dc.source.issue10en_US
dc.identifier.doi10.1371/journal.pone.0276955
dc.identifier.cristin2084053
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal